Oral administration of KW-5092, a novel gastroprokinetic...

Oral administration of KW-5092, a novel gastroprokinetic agent with acetylcholinesterase inhibitory and acetylcholine release enhancing activities, causes a dose-dependent increase in the blood acetylcholine content of beagle dogs

Shin Yamada, Takeshi Fujii, Koichiro Kawashima
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
225
Year:
1997
Language:
english
DOI:
10.1016/s0304-3940(97)00188-2
File:
PDF, 121 KB
english, 1997
Conversion to is in progress
Conversion to is failed